Continue to Site

Pharmaceutical Processing World

FDA postpones some inspectional activities amid omicron surge

By |

coronavirus COVID-19 Pfizer

[Photo by Fusion Medical Animation on Unsplash]

The FDA announced earlier this week that it made some temporary changes to its inspectional activities due to COVID-19.

With the omicron variant of the virus causing surges across the world, the FDA implemented the changes in the U.S. on Dec. 29, 2021, to ensure the safety of its employees and the firms it regulates, according to a news release.

Get the full story at our sister site, Medical Design & Outsourcing.

About The Author

Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Tell Us What You Think!

Related Articles Read More >

Search Pharmaceutical Processing World